241 related articles for article (PubMed ID: 23644778)
41. Sudden cardiac death in Andersen-Tawil syndrome.
Peters S; Schulze-Bahr E; Etheridge SP; Tristani-Firouzi M
Europace; 2007 Mar; 9(3):162-6. PubMed ID: 17272325
[TBL] [Abstract][Full Text] [Related]
42. In vivo and in vitro functional characterization of Andersen's syndrome mutations.
Bendahhou S; Fournier E; Sternberg D; Bassez G; Furby A; Sereni C; Donaldson MR; Larroque MM; Fontaine B; Barhanin J
J Physiol; 2005 Jun; 565(Pt 3):731-41. PubMed ID: 15831539
[TBL] [Abstract][Full Text] [Related]
43. Management and treatment of Andersen-Tawil syndrome (ATS).
Sansone V; Tawil R
Neurotherapeutics; 2007 Apr; 4(2):233-7. PubMed ID: 17395133
[TBL] [Abstract][Full Text] [Related]
44. Andersen-Tawil syndrome: clinical and molecular aspects.
Nguyen HL; Pieper GH; Wilders R
Int J Cardiol; 2013 Dec; 170(1):1-16. PubMed ID: 24383070
[TBL] [Abstract][Full Text] [Related]
45. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
[TBL] [Abstract][Full Text] [Related]
46. Andersen-Tawil syndrome: prospective cohort analysis and expansion of the phenotype.
Yoon G; Oberoi S; Tristani-Firouzi M; Etheridge SP; Quitania L; Kramer JH; Miller BL; Fu YH; Ptácek LJ
Am J Med Genet A; 2006 Feb; 140(4):312-21. PubMed ID: 16419128
[TBL] [Abstract][Full Text] [Related]
47. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome.
Donaldson MR; Jensen JL; Tristani-Firouzi M; Tawil R; Bendahhou S; Suarez WA; Cobo AM; Poza JJ; Behr E; Wagstaff J; Szepetowski P; Pereira S; Mozaffar T; Escolar DM; Fu YH; Ptácek LJ
Neurology; 2003 Jun; 60(11):1811-6. PubMed ID: 12796536
[TBL] [Abstract][Full Text] [Related]
48. Reversible Dilated Cardiomyopathy Caused by a High Burden of Ventricular Arrhythmias in Andersen-Tawil Syndrome.
Rezazadeh S; Guo J; Duff HJ; Ferrier RA; Gerull B
Can J Cardiol; 2016 Dec; 32(12):1576.e15-1576.e18. PubMed ID: 27789106
[TBL] [Abstract][Full Text] [Related]
49. KCNJ2 variant of unknown significance reclassified as long QT syndrome causing ventricular fibrillation.
Obeyesekere MN; Klein GJ; Conacher S; Krahn AD
Can J Cardiol; 2011; 27(6):870.e11-3. PubMed ID: 21875779
[TBL] [Abstract][Full Text] [Related]
50. [A new type of periodic paralysis: Andersen-Tawil syndrome].
Pouget J
Bull Acad Natl Med; 2008 Nov; 192(8):1551-6; discussion 1556-7. PubMed ID: 19445372
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
[TBL] [Abstract][Full Text] [Related]
52. Loss-of-function mutations of the K(+) channel gene KCNJ2 constitute a rare cause of long QT syndrome.
Fodstad H; Swan H; Auberson M; Gautschi I; Loffing J; Schild L; Kontula K
J Mol Cell Cardiol; 2004 Aug; 37(2):593-602. PubMed ID: 15276028
[TBL] [Abstract][Full Text] [Related]
53. Compound heterozygous mutations in
Polyak ME; Shestak A; Podolyak D; Zaklyazminskaya E
BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843460
[TBL] [Abstract][Full Text] [Related]
54. An andersen-Tawil syndrome mutation in Kir2.1 (V302M) alters the G-loop cytoplasmic K+ conduction pathway.
Ma D; Tang XD; Rogers TB; Welling PA
J Biol Chem; 2007 Feb; 282(8):5781-9. PubMed ID: 17166852
[TBL] [Abstract][Full Text] [Related]
55. Bioelectric signalling via potassium channels: a mechanism for craniofacial dysmorphogenesis in KCNJ2-associated Andersen-Tawil Syndrome.
Adams DS; Uzel SG; Akagi J; Wlodkowic D; Andreeva V; Yelick PC; Devitt-Lee A; Pare JF; Levin M
J Physiol; 2016 Jun; 594(12):3245-70. PubMed ID: 26864374
[TBL] [Abstract][Full Text] [Related]
56. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).
Tristani-Firouzi M; Jensen JL; Donaldson MR; Sansone V; Meola G; Hahn A; Bendahhou S; Kwiecinski H; Fidzianska A; Plaster N; Fu YH; Ptacek LJ; Tawil R
J Clin Invest; 2002 Aug; 110(3):381-8. PubMed ID: 12163457
[TBL] [Abstract][Full Text] [Related]
57. Case report: A Chinese child with Andersen-Tawil syndrome due to a de novo KCNJ2 mutation.
Liu XL; Huang XJ; Luan XH; Zhou HY; Wang T; Wang JY; Shen JY; Chen SD; Tang HD; Cao L
J Neurol Sci; 2015 May; 352(1-2):105-6. PubMed ID: 25847018
[No Abstract] [Full Text] [Related]
58. Andersen-Tawil Syndrome: A Comprehensive Review.
Pérez-Riera AR; Barbosa-Barros R; Samesina N; Pastore CA; Scanavacca M; Daminello-Raimundo R; de Abreu LC; Nikus K; Brugada P
Cardiol Rev; 2021 Jul-Aug 01; 29(4):165-177. PubMed ID: 32947483
[TBL] [Abstract][Full Text] [Related]
59. Extracellular Kir2.1
Cruz FM; Macías Á; Moreno-Manuel AI; Gutiérrez LK; Vera-Pedrosa ML; Martínez-Carrascoso I; Sánchez Pérez P; Ruiz Robles JM; Bermúdez-Jiménez FJ; Díaz-Agustín A; Martínez de Benito F; Arias-Santiago S; Braza-Boils A; Martín-Martínez M; Gutierrez-Rodríguez M; Bernal JA; Zorio E; Jiménez-Jaimez J; Jalife J
Circ Res; 2024 Apr; 134(8):e52-e71. PubMed ID: 38497220
[TBL] [Abstract][Full Text] [Related]
60. Phenotypic Variability of Andersen-Tawil Syndrome Due to Allelic Mutation c.652C>T in the
Onore ME; Picillo E; D'Ambrosio P; Morra S; Nigro V; Politano L
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
